The deuterated pyrazoloquinolinone targeting α6 subunit-containing GABAA receptor as novel candidate for inhibition of trigeminovascular system activation: implication for migraine therapy
Article in Frontiers in Pharmacology (August 2024)
The most recent citing publications are shown below. View all 12 publications that cite this research output on Dimensions.
Article in Frontiers in Pharmacology (August 2024)
Article in Journal of Clinical Medicine (December 2022)
Book chapter (November 2022)